[ ]* career at RPAN was short-lived. On becoming [ ]* in March 1998, [ ]* authorised the company's executives to resume/continue communications with their competitors; the quarterly meetings were, however, to be discontinued, presumably because of their high visibility and the associated risk of discovery (by this time the investigations of the US antitrust authorities in the vitamins sector were already well advanced).
Recital 181, Decision_act (EU) 2003/674
In forcesince 2 Jul 2002